uniQure N.V (NASDAQ: QURE) on Monday, soared 4.72% from the previous trading day, before settling in for the closing price of $19.51. Within the past 52 weeks, QURE’s price has moved between $7.76 and $71.50.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.66%. The company achieved an average annual earnings per share of 21.17%. With a float of $56.77 million, this company’s outstanding shares have now reached $62.17 million.
uniQure N.V (QURE) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of uniQure N.V is 7.85%, while institutional ownership is 89.81%. The most recent insider transaction that took place on Nov 06 ’25, was worth 856,881. In this transaction Director of this company sold 31,434 shares at a rate of $27.26, taking the stock ownership to the 40,145 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director sold 38,810 for $30.34, making the entire transaction worth $1,177,517. This insider now owns 20,439 shares in total.
uniQure N.V (QURE) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.44 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.52) by -0.92. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.45% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
uniQure N.V (QURE) is currently performing well based on its current performance indicators. A quick ratio of 7.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 79.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.39, a number that is poised to hit -0.92 in the next quarter and is forecasted to reach -3.21 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
The latest stats from [uniQure N.V, QURE] show that its last 5-days average volume of 2.47 million was superior to 2.26 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 7.50%.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 13.69%, which indicates a significant increase from 12.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.35 in the past 14 days, which was lower than the 2.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.82, while its 200-day Moving Average is $22.37. Now, the first resistance to watch is $20.93. This is followed by the second major resistance level at $21.43. The third major resistance level sits at $22.25. If the price goes on to break the first support level at $19.61, it is likely to go to the next support level at $18.79. Assuming the price breaks the second support level, the third support level stands at $18.29.
uniQure N.V (NASDAQ: QURE) Key Stats
Market capitalization of the company is 1.26 billion based on 62,292K outstanding shares. Right now, sales total 27,120 K and income totals -239,560 K. The company made 3,700 K in profit during its latest quarter, and -80,530 K in sales during its previous quarter.
